A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-alpha) vs. Eprex® in patients with anaemia of chronic renal failure
- Publication date
- 1 November 2021
- Publisher
- 'Springer Science and Business Media LLC'